Zobrazeno 1 - 10
of 274
pro vyhledávání: ''
Autor:
Richard L. Weinberg, Robin B. Marsh, Hunter C. Gits, Matthew J. Schipper, Reshma Jagsi, Venkatesh L. Murthy, Lori J. Pierce, Ming Tang, Eleanor M. Walker, Corey Speers, James A. Hayman, James M. Balter, Carri K Glide-Hurst, Emily Morris, Mary Feng, Jean M. Moran
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:417-425
Purpose Radiation therapy (RT) can increase the risk of cardiac events in patients with breast cancer (BC), but biomarkers predicting risk for developing RT-induced cardiac disease are currently lacking. We report results from a prospective clinical
Autor:
Hee Yeon Kim, Eun-Tae Park, Sae-Gwang Park, Mi Seon Kang, Sung Jae Park, Young Kyeong Seo, Anbok Lee, Jin-Hee Park, Il Hwan Kim
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:510-520
Purpose The establishment of a preclinical model of the abscopal effect on hepatocellular carcinoma (HCC) and evaluation of whether the hypofractionated radiation therapy (RT) multitumor Hepa1-6 mouse HCC model could be used to suppress nonradiated t
Autor:
Sukanta Kamila, Michael D. Gray, John F. Callan, Borivoj Vojnovic, Anne E. Kiltie, Anthony P. McHale, Jia Ling Ruan, Richard Browning, Amy J. Elliott, Yesna O. Yildiz, Eleanor Stride, James R. Thompson, Luca Bau, Sean Smart
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics
Purpose: Chemoradiation is the standard of care in muscle-invasive bladder. While agents such as gemcitabine can enhance tumour radiosensitisation, their side effects can limit patient eligibility and treatment efficacy. Here we investigate ultrasoun
Autor:
Yongsheng Wang, Di-Yuan Qin, Youling Gong, Fuchun Guo, Li Xiang, Xiaoyu Li, Xiaoke Liu, Yuhong Ou, Li Jiang, Qing Qin, Zeming Mo, Pei Shu, Dan Li, Xin Wang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 107:804-814
Purpose To determine the role of NLRP3 inflammasome activation in low-dose radiation-induced radiation pneumonitis (RP) and to assess whether inhibition or deletion of the NLRP3 inflammasome is critical for conferring protection against RP. Methods a
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 107:12-17
Autor:
M. Beth McCarville, Alberto S. Pappo, Kirsten K. Ness, Christopher L. Tinkle, Matthew J. Krasin, Barry L. Shulkin, Jianrong Wu, Thomas E. Merchant, Chia-Ho Hua, Armita Bahrami, Sue C. Kaste, Sheri L. Spunt, Shenghua Mao, Andrew M. Davidoff, Daniel M. Green
Publikováno v:
Int J Radiat Oncol Biol Phys
PURPOSE: Our purpose was to assess disease outcomes and late toxicities in pediatric patients with rhabdomyosarcoma treated with conformal photon radiation therapy (RT). METHODS AND MATERIALS: Sixty-eight patients (median age, 6.9 years) were treated
Autor:
Tracey E. Schefter, Moyed Miften, Edward M. Castillo, Brian D. Kavanagh, Inga S. Grills, Nicholas Myziuk, Quentin Diot, Daniel W. Bowles, Thomas Guerrero, Laurie E. Gaspar, Yevgeniy Vinogradskiy, Richard Castillo, Bernard L. Jones, Craig W. Stevens, Jennifer J. Kwak, Chad G. Rusthoven
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Studies have noted a link between radiation dose to the heart and overall survival (OS) for patients with lung cancer treated with chemoradiation. The purpose of this study was to characterize pre- to posttreatment cardiac metabolic changes u
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e132-e133
PURPOSE/OBJECTIVE(S) Focal liver reactions (FLR) in areas of prior radiation therapy (RT) on MRI are a phenomenon that has been reported in small series. However, little is known about the temporality and dosimetry of FLR and how they evolve over tim
Autor:
Olmo Zavala-Romero, Adrian L. Breto, Radka Stoyanova, K. Cullison, Eric A. Mellon, K. Jones, John C. Ford
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e89-e90
Purpose/Objective(s) Recently identified changes in brain during daily MRI-guided radiation therapy (MRgRT) of patients with glioblastoma (GBM) can permit adaptive radiotherapy. However, daily changes can be subtle to detect and difficult to evaluate
Autor:
Raju Raval, Paul D. Brown, Douglas A. Hardesty, Vinai Gondi, S. Beyer, Mario Ammirati, Shirley Ong, Joshua D. Palmer, H.K. Perlow, Dukagjin Blakaj, Brett Klamer, C. Pillainayagam, J. Goranovich, Pierre Giglio, John C. Grecula, Arnab Chakravarti, Russell R. Lonser, M. Yang, A.L.H. Arnett, James B. Elder
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e597-e598
PURPOSE/OBJECTIVE(S) The standard of care for elderly glioblastoma patients (GBM) is 40 Gy in 15 fractions with temozolomide (TMZ). However, this regimen has a lower biologic equivalent dose (BED) compared to the Stupp regimen of 60 Gy in 30 fraction